During the past decade, IRCCS Multimedica conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "IRCCS Multimedica" #1 sponsor was "Boehringer Ingelheim" with 3 trials, followed by "Clinica Mediterranea" with 3 trials sponsored, "IRCCS San Raffaele" with 2 trials sponsored, "Iperboreal Pharma Srl" with 2 trials sponsored and "Biotronik SE & Co. KG" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "IRCCS Multimedica" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "University Hospital of Ferrara" with 2 trials as a collaborator, "ASST Cremona" with 1 trials as a collaborator, "AUSL Romagna Rimini" with 1 trials as a collaborator and "Arcispedale Santa Maria Nuova-IRCCS" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "IRCCS Multimedica" are "End Stage Renal Disease" (2 trials), "Heart Failure" (2 trials), "Acute Coronary Syndrome" (1 trials), "Acute Coronary Syndromes" (1 trials) and "Bleeding" (1 trials). Many other conditions were trialed in "IRCCS Multimedica" in a lesser frequency.

Most popular intervention types in "IRCCS Multimedica" are "Drug" (8 trials), "Device" (3 trials), "Procedure" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Empagliflozin" (2 trials), "Placebo" (2 trials), "Bivalirudin" (1 trials), "Cardiac magnetic resonance" (1 trials) and "Coronary angiography using DyeVert system" (1 trials). Other intervention names were less common.

The vast majority of trials in "IRCCS Multimedica" are 15 trials for "All" genders.

Currently, there are NaN active trials in "IRCCS Multimedica". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in IRCCS Multimedica, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in IRCCS Multimedica, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".